Evidence map›Paper›PMID 20686084›Full record

ArticleJournal of clinical microbiology2010

Evaluation of the Capilia TB assay for culture confirmation of Mycobacterium tuberculosis infections in Zambia and South Africa.

Monde Muyoyeta, Petra E W de Haas, Dirk H Mueller, Paul D van Helden, Lawrence Mwenge, Ab Schaap, Clarissa Kruger, Nicolaas C Gey van Pittius, Katherine Lawrence, Nulda Beyers and 2 more

Abstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. [Identification ofZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2016
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Monde MuyoyetaZambia AIDS Related Tuberculosis (ZAMBART), University of Zambia School of Medicine, Lusaka, Zambia. monde@zambart.org.zm
Petra E W de Haas
Dirk H Mueller
Paul D van Helden
Lawrence Mwenge
Ab Schaap
Clarissa Kruger
Nicolaas C Gey van Pittius
Katherine Lawrence
Nulda Beyers
Peter Godfrey-Faussett
Helen Ayles

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The performance and cost of the Capilia TB assay were evaluated for use in a resource-limited setting. The sensitivity and specificity were 99.6% and 99.5%, respectively. The incremental costs of the Capilia test were estimated to be $1.46 and $1.84 when the test was added to liquid and solid culture processes, respectively. These findings suggest that the Capilia TB assay represents a rapid, simple, and inexpensive Mycobacterium tuberculosis identification test that can be used in resource-limited settings.

Indexed as

Bacteriological TechniquesHumansMycobacterium tuberculosisSensitivity and SpecificitySouth AfricaTime FactorsTuberculosisZambia

Identifiers

PMID20686084
PMCPMC2953073

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.